http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130127515-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0855db861a7d400da0a3396cc16d77e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
filingDate | 2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_923c2e2013c32241f909e69de15a9ca1 |
publicationDate | 2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20130127515-A |
titleOfInvention | Combination of pyrimidine-containing NNTRI and RT inhibitors |
abstract | The present invention relates to NNRTI, designated TMC278, useful for the treatment of HIV-infected patients or for preventing HIV transmission or infection, as nucleoside reverse transcriptase inhibitors such as emtricitabine, lamivudine or abakavir and / or nucleotide reverse transcriptase inhibitors. And to pyrimidine blends comprising tenofovir. |
priorityDate | 2003-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1038.